Luis Querol Selected Research

Luis Querol Research Topics

Disease

24	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 06/2022 - 03/2013
9	Myasthenia Gravis 01/2022 - 10/2013
8	Polyneuropathies (Polyneuropathy) 01/2019 - 03/2013
6	Tremor (Tremors) 06/2022 - 03/2014
4	Ataxia (Dyssynergia) 06/2022 - 09/2018
4	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 03/2014
4	Thymoma (Thymic Carcinoma) 01/2021 - 01/2014
4	Multiple Sclerosis 01/2019 - 06/2013
4	Autoimmune Diseases (Autoimmune Disease) 09/2017 - 06/2013
3	Guillain-Barre Syndrome 11/2021 - 11/2020
2	Neuralgia (Stump Neuralgia) 11/2021 - 01/2021
2	Pain (Aches) 11/2021 - 01/2021
2	Neoplasms (Cancer) 05/2018 - 09/2017
1	COVID-19 01/2022
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Encephalitis (Encephalitis, Rasmussen) 01/2022
1	Infections 01/2022
1	Leukocytosis (Pleocytosis) 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 01/2022
1	Seizures (Absence Seizure) 01/2022
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022
1	Neuroblastoma 11/2021
1	Hypertrophy 06/2021
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Paralysis (Palsy) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2019
1	Disease Progression 09/2019
1	Relapsing-Remitting Multiple Sclerosis 01/2019
1	Paraproteinemias (Monoclonal Gammopathy) 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Dysferlinopathy 10/2018
1	Paraneoplastic Polyneuropathy 05/2018
1	Nervous System Diseases (Neurological Disorders) 05/2018
1	Gait Ataxia 01/2016
1	Clinical Deterioration 01/2016
1	Muscle Weakness 10/2014
1	Muscular Diseases (Myopathy) 07/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2014
1	Polyradiculoneuropathy (Polyradiculoneuritis) 03/2014
1	Atherosclerosis 11/2013
1	Stroke (Strokes) 11/2013
1	Ischemic Stroke 11/2013
1	Epstein-Barr Virus Infections 09/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2013

Drug/Important Bio-Agent (IBA)

23	AntibodiesIBA 06/2022 - 03/2013
18	AutoantibodiesIBA 06/2022 - 06/2013
10	Proteins (Proteins, Gene)FDA Link 06/2022 - 09/2013
10	Immunoglobulin G (IgG)IBA 01/2022 - 09/2013
9	Intravenous Immunoglobulins (IVIG)FDA Link 11/2021 - 12/2013
7	Rituximab (Mabthera)FDA Link 01/2022 - 10/2013
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2013
6	AntigensIBA 05/2018 - 03/2013
5	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 10/2015
4	Cholinergic ReceptorsIBA 01/2021 - 01/2014
3	Pharmaceutical PreparationsIBA 11/2021 - 01/2020
3	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 09/2013
2	GangliosidesIBA 06/2022 - 11/2021
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2021 - 01/2021
2	Anti-Idiotypic AntibodiesIBA 11/2021 - 04/2018
2	Contactin 1IBA 01/2021 - 03/2014
2	Immunoglobulin M (IgM)IBA 01/2020 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2018 - 06/2016
2	muskIBA 06/2016 - 01/2016
2	CortactinIBA 01/2016 - 10/2014
2	AutoantigensIBA 09/2013 - 06/2013
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	VaccinesIBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022
1	GadoliniumIBA 06/2021
1	COVID-19 VaccinesIBA 01/2021
1	CytokinesIBA 01/2020
1	Complement System Proteins (Complement)IBA 10/2019
1	human GAA protein (Myozyme)FDA Link 09/2019
1	Myelin-Associated GlycoproteinIBA 01/2019
1	Interferon-betaIBA 01/2019
1	InterferonsIBA 01/2019
1	PerforinIBA 01/2019
1	DysferlinIBA 10/2018
1	Cell Adhesion MoleculesIBA 05/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2017
1	Protein Isoforms (Isoforms)IBA 07/2017
1	Potassium Channels (Potassium Channel)IBA 01/2017
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016
1	Nucleic AcidsIBA 07/2014
1	Polysaccharides (Glycans)IBA 03/2014
1	MicroRNAs (MicroRNA)IBA 01/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2013
1	erucylphosphocholineIBA 11/2013
1	Biological ProductsIBA 10/2013
1	eculizumab FDA Link 10/2013

Therapy/Procedure

4	Immunotherapy 01/2022 - 10/2013
3	Therapeutics 04/2018 - 03/2013
2	Plasma Exchange 11/2021 - 01/2021